Vaccines MarketThe global vaccines market is on a robust growth trajectory, projected to rise from USD 42.7 billion in 2023 ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Meningitis C cases are down 99% since the NHS routine vaccination programme was introduced by UKHSA and NHS England in 1999.

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

There were just three cases of meningococcal group C - the infection which can lead to meningitis C - last year, the UK ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...

However, medical experts warn that too many children are still not fully vaccinated and ensuring their protection is as ...

DOHA: The Ministry of Public Health has announced updated health requirements for individuals travelling to perform Umrah or ...

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation.

The British pharmaceutical company said Wednesday that the fully liquid vaccine supports simplifying the vaccination process against invasive meningococcal disease, or IMD, as it offers healthcare ...